SEMAVI 0.25MG INJ

SEMAVI 0.25MG is a semaglutide injection used for managing type 2 diabetes and weight management. Each injection delivers 0.25mg of semaglutide, a GLP-1 receptor agonist that helps regulate blood sugar levels and reduce appetite. Administered once weekly, it works by stimulating insulin secretion and slowing gastric emptying. Suitable for adults requiring glycemic control or weight loss support. Store between 2-8°C before use. Always follow your healthcare provider's dosing instructions and monitor for any adverse effects during treatment.